← Back to News

Daily IV Report

Mid-session IV Report June 21, 2024

Mid-session IV Report June 21, 2024 The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By this often over looked information. Options with increasing option implied volatility: SNAP NFLX TSM ASML UAL ALGN CMG DPZ ISRG Popular stocks with increasing volume: MU […]

By Market Rebellion · June 21, 2024
Mid-session IV Report June 21, 2024

Mid-session IV Report June 21, 2024

The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By this often over looked information.

Options with increasing option implied volatility: SNAP NFLX TSM ASML UAL ALGN CMG DPZ ISRG

Popular stocks with increasing volume: MU SMCI ARM DELL COIN JPM AVGO TGT

Active options: NVDA TSLA AAPL AMZN AMD PLTR MU MSFT GME GOOGL MARA SMCI META GOOG ARM DELL COIN JPM AVGO TGT

Option IV into quarter results

FedEx (FDX) June weekly call option implied volatility is at 68, July is at 40; compared to its 52-week range of 18 to 38 into the expected release of quarter results after the bell on June 25.

Carnival Cruise Lines (CCL) June weekly call option implied volatility is at 80, July is at 52; compared to its 52-week range of 36 to 63 into the expected release of quarter results before the bell on June 25.

NVIDIA (NVDA) 4M contracts trade with focus on 9,999 contracts of July 19 2024 138 puts trading at $15 for a dollar value of $150K as share price at $125.84.

Apple (AAPL) 14,769 contracts of July 19 24 2024 210 puts purchased on the offer for $4.15 and 14,769 contracts of July 19 2024 210 puts purchased on the offer for $4.15.

Sarepta Therapeutics (SRPT) call put ratio 2.9 calls to 1 put on 33K option contracts with a focus on 3400 contracts of August 175 calls trading at $8.50 for a dollar value of $28,500 as share price up 36%.

Sarepta Therapeutics (SRPT) 30-day option implied volatility is at 49; compared to its 52-week range of 38 to 238. Call put ratio 2.9 calls to 1 put as share price up 38% after expanded FDA approval of Elevidys for DMD.

Smith & Wesson Brands (SWBI) total option volume of 9K options contracts trade with focus on 500 contracts of June 12.50 trading at 3 cents and 500 contracts of June 15 puts trading at 40 cents into expiration as share price down 10.4% to $14.64.

Options with decreasing option implied volatility: GME SPRT RH ADBE KMX CAN KR CPRI LEN HYG
Increasing unusual option volume: PPL SWBI SARK SRPT CNK NVD MTN EWT FFIE PCT GILD
Increasing unusual call option volume: SWBI PPL SRPT CNK NVD TXN GILD KMX SIRI
Increasing unusual put option volume: ZI ASTS SRPT EWT CORZ PCT KMX HE APLS FMC